More on CELC
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $61.56 |
|
|||
| Open | $61.74 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $66.93 | ||||
| Day Low | $61.74 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,932,806 | ||||
- Cantor sees ‘credible path to multi-billion-dollar peak sales’ for Celcuity
- Cantor Fitzgerald Starts Celcuity Inc (CELC) at Overweight
- TD Cowen establishes a $145 target on Celcuity Inc (CELC)
- Celcuity (CELC) Reiterated at Market Outperform by Citizens Before VIKTORIA-1 Ph3 Results
- Form 4 Celcuity Inc. For: Oct 07 Filed by: Furcht Leo
- Form 4 Celcuity Inc. For: Oct 01 Filed by: GRYSKA DAVID W
- Form 3 Celcuity Inc. For: Oct 01 Filed by: GRYSKA DAVID W
- Celcuity to present gedatolisib trial data at ESMO 2026
- Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026
- Form 8-K Celcuity Inc. For: Oct 01
Entities mentioned with CELC
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
